
Kymera Therapeutics, Inc.
USD109.32
+1.20 (+1.11%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$106.96
Prev. Close
$108.12
Day Low
$105.00
Day High
$111.96
52W Low
$36.65
52W High
$130.05
Market Cap
$8.99B
Volume
1.68M
| 25 Jun 2026 |
| BTIG |
| Buy |
| Buy |
| maintain |
| 3 Mar 2026 | UBS | Buy | Buy | maintain |
| 2 Mar 2026 | Stephens & Co. | Overweight | Overweight | maintain |
| 2 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 26 Feb 2026 | BTIG | Buy | Buy | maintain |
| 26 Feb 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 3 Feb 2026 | BTIG | Buy | Buy | maintain |